Search - tctmd.com

Displaying 661 - 680 of 874

Sort: Relevancy | Date

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-Expanding Aortic Bioprosthesis in Patients with Severe Aortic Stenosis

Presenter: Thomas F. Luscher, Patrick W. Serruys, Stephan Windecker

October 31, 2016

Presentation TCT 2016

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Erik W. Holy

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Presenter: Dmitriy N. Feldman, Rahul Sakhuja

October 31, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti

October 30, 2016

Presentation TCT 2016

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Howard C. Herrmann

October 30, 2016

Presentation TCT 2016

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

Presenter: A. Pieter Kappetein, Allan Schwartz, Philippe Pibarot

October 30, 2016

Presentation TCT 2016

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams

October 30, 2016

Presentation TCT 2016

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Michael Haude

October 30, 2016

Advertisement

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-Expanding Aortic Bioprosthesis in Patients with Severe Aortic Stenosis

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content